Status:
UNKNOWN
Tight Control Management in Perianal Crohn's Disease
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Inflammatory Bowel Diseases
Perianal Fistula
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Perianal Crohn's disease (pCD) affects around one-third of patients with Crohn's disease (CD) during their disease course. It represents a distinct disease phenotype and causes significant morbidity, ...
Detailed Description
Perianal Crohn's disease (pCD) affects around one-third of patients with Crohn's disease (CD) during their disease course. It represents a distinct disease phenotype and causes significant morbidity, ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Confirmed diagnosis of perianal Crohn's disease
- On biologics or will start biologics
Exclusion
- Patients who have perianal fistula due to causes other than Crohn's disease
- Patients who have allergic reaction / contraindications to anti-TNF
- Patients who have active cancer
- Patients who have contraindications for MRI
- Known pregnancy
- For patients who refuse to participate in the tight monitoring arm, they will be consented and recruited to the control arm for comparison.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03861689
Start Date
July 1 2019
End Date
June 30 2024
Last Update
January 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong